P
Passage Bio D
D
PASG
0.77000
USD
0.13
(20.05%)
Market Closed
Volume
13,950
EPS
-1
Div Yield
-
P/E
-1
Market Cap
47,560,810
Novo Nordisk Surges in Profit and Sales
6 months ago
Stocks news More
Title: Passage Bio
Sector: Healthcare
Industry: Biotechnology
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease.